Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017507 · ClinicalTrials.gov registry record
The Effects of Oscillating-Rotating Electric Toothbrushes on Plaque and Gingival Health
A clinical trial, sponsored by Procter and Gamble.
- Completed
- Registry status
- 2,145
- Enrollment target
NCT04017507: Completed study, sponsored by Procter and Gamble.
NCT04017507 is a clinical trial that has completed, run by Procter and Gamble. The registered enrollment target is 2,145 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04017507 has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- 2,145 participants
- Enrollment target
Study Summary
The aim of this analysis was to compare the effects of oscillating-rotating (O-R), side-to-side (sonic), and manual toothbrushes on plaque and gingival health after multiple uses.
Primary Outcome
Change from baseline as measured on number of bleeding sites ( via gingival bleeding index, Loe Silness index, Papillary bleeding index or Mazza gingival index).
Interventions
- DEVICE Manual toothbrush
- DEVICE Oscillating-rotating electric toothbrush
- DEVICE Side-to-side electric toothbrush
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,145 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2018-11-30 |
What the finished NCT04017507 record still lists
NCT04017507 is an observational study that tracks outcomes without assigning an intervention. Its 2,145 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Manual toothbrush is the first listed.
NCT04017507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04017507 about?
NCT04017507 is a clinical study titled "The Effects of Oscillating-Rotating Electric Toothbrushes on Plaque and Gingival Health". The aim of this analysis was to compare the effects of oscillating-rotating (O-R), side-to-side (sonic), and manual toothbrushes on plaque and gingival health after multiple uses.
What is the current status of trial NCT04017507?
This trial is currently completed. The enrollment target is 2,145 participants. The study started on 2018-01-08. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT04017507?
The interventions under investigation include: Manual toothbrush (DEVICE), Oscillating-rotating electric toothbrush (DEVICE), Side-to-side electric toothbrush (DEVICE).
Who is sponsoring clinical trial NCT04017507?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- NCT06598475 · 2,142 participants · NA
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT03488693 · 2,140 participants · Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI